metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica ¿Podemos prevenir las enfermedades transmitidas por garrapatas?
Información de la revista
Vol. 19. Núm. 10.
Páginas 509-513 (diciembre 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. 10.
Páginas 509-513 (diciembre 2001)
Acceso a texto completo
¿Podemos prevenir las enfermedades transmitidas por garrapatas?
Visitas
12736
José A. Oteo1
Autor para correspondencia
medoteo@saludalia.com

Correspondencia: Dr. J. A. Oteo. Servicio de Medicina Interna y Enfermedades Infecciosas. Hospital de La Rioja. Avda de Viana Nº 1. 26001 Logroño
, José R. Blanco, Valvanera Ibarra
Servicio de Medicina Interna y Enfermedades Infecciosas. Hospital de La Rioja Logroño
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P. Parola, D. Raoult.
Ticks and tickborne bacterial diseases in humans: an emerging infectious threat.
Clin Infect Dis, 32 (2001), pp. 897-928
[2.]
J.A. Steenland.
Garrapatas: cien años como vector.
Rev Clin Esp, 195 (1995), pp. 1-2
[3.]
D.H. Spach, W.C. Liles, G.L. Campbell, R.E. Quick, D.E Anderson, Th.R. Fritsche.
Tick–borne diseases in the United States.
N Engl J Med, 329 (1993), pp. 936-947
[4.]
A. Estrada, J.J. Osacar, C. Cortázar, C. Calvete, J. Lucientes.
An account of the ticks from the northeast of Spain.
Ann Parasit, 67 (1992), pp. 42-49
[5.]
J.A. Oteo Revuelta.
Tick–borne diseases in Spain.
Clin Microbiol Infect, 1 (2001), pp. 31
[6.]
B. Font, E. Espejo, T. Muñoz, S. Uriz, F. Bella, F. Segura.
Fiebre botonosa mediterránea. Estudio de 246 casos.
Med Clin (Barc), 96 (1991), pp. 121-125
[7.]
J.A. Oteo, A. Estrada.
Babesiosis humana. Estudio de vectores.
Enf Infecc Microbiol Clin, (1992), pp. 466-469
[8.]
Oteo JA, Martínez de Artola V, Casa JM. Tick-borne diseases in Spain. Abstract book of the 6th International Congress for Infectious Diseases. Prague (Czech Republic) 1994; A660
[9.]
J.A. Oteo, J.R. Maraví, V. Martínez de Artola, P. Antuñano.
Parálisis por mordedura de garrapata.
Med Clin (Barc), 94 (1990), pp. 275-276
[10.]
J.A. Oteo, J.R. Blanco, V.M. de Artola, V. Ibarra.
First report of Human Granulocytic Ehrlichiosis from Southern Europe (Spain).
Emerg Infect Dis, 6 (2000), pp. 430-431
[11.]
J.A. Oteo, V. Gil, M. Barral, A. Pérez, S. Jiménez, J.R. Blanco, et al.
Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja. Spain.
Epidemiol Infect, 127 (2001), pp. 353
[12.]
Oteo JA, Ibarra V. Dermacentor Borne Necrosis Eritema Linfadenopatía (DEBONEL). ¿Una nueva enfermedad transmitida por garrapatas? Enferm Infecc Microbiol Clin (en prensa)
[13.]
A. Guerrero, R. Escudero, P. Martí-Belda, C. Quereda.
Frecuencia de las manifestaciones clínicas de la borreliosis de Lyme en España.
Enferm Infecc Microbiol Clin, 14 (1996), pp. 72-79
[14.]
J.A. Oteo Revuelta, J.R. Blanco Ramos, V. Martínez de Artola, R. Grandival García, V. Ibarra Cucalón, V. Dopereiro Gómez.
Eritema migratorio (borreliosis de Lyme). Características clinico-epidemiológicas de 50 pacientes.
Rev Clin Esp, 200 (2000), pp. 60-63
[15.]
J.A. Oteo, V. Martínez de Artola, R. Gómez–Cadiñanos, J.M. Casa, J.R. Blanco, L. Rosel.
Evaluación de los métodos de retirada de las garrapatas en la ixodidiasis humana.
Rev Clin Esp, 196 (1996), pp. 584-587
[16.]
J.A. Oteo, V. Martínez de Artola.
Borreliosis de Lyme: aspectos epidemiológicos y etiopatogenia.
Enf Infecc y Microbiol Clin, 13 (1995), pp. 557-558
[17.]
J.A. Oteo, J.M. Casa, V. Martínez de Artola.
Lyme disease in outdoor workers: risk factors, preventive measures and tick removal methods.
Am J Epidemiol, 133 (1991), pp. 754-755
[18.]
C.M. Costello, A.C. Steere, R.E. Pinkerton, H.M. Feder.
A prospective study of tick bites in an endemic area for Lyme disease.
J Infect Dis, 159 (1989), pp. 136-139
[19.]
J.A. Oteo, A. Oksa.
Garrapatas infectadas por Borrelia burgdorferi (enfermedad de Lyme). Estudio de 4.662 garrapatas (Ixodioidea) en la Comunidad Autónoma de La Rioja.
Enferm Infecc Microbiol Clin, 10 (1992), pp. 139
[20.]
M. Brown, A.A. Hebert.
Insect repellents: an overview.
J Am Acad Dermatol, 36 (1997), pp. 243-249
[21.]
K.L. Curran, D. Fish.
Increased risk of Lyme disease for cat owners.
N Engl J Med, 320 (1989), pp. 183
[22.]
T.L. Schulze, R.A. Jordan, R.W. Hung.
Suppression of Ixodes scapularis (Acari: Ixodidae) after remoal of leaf litter.
J Med Entomol, 32 (1995), pp. 730-733
[23.]
K.L. Curran, D. Fish, J. Piesman.
Reduction of nymphal Ixodes dammini (Acari: Ixodidae) in a residential suburban landscape by area application of insecticides.
J Med Entomol, 30 (1993), pp. 107-113
[24.]
J. Piesman, T.N. Mather, R.J. Sinsky, A. Spielman.
Duration of tick attachment and Borrelia burgdorferi transmission.
J Clin Microbiol, 25 (1987), pp. 557-558
[25.]
S.K. Sood, M.B. Salzman, B.J. Johnson, C.M. Happ, K. Feig, L. Carmody, et al.
Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic.
J Infect Dis, 175 (1997), pp. 996-999
[26.]
J. Piesman.
Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks.
J Infect Dis, 167 (1993), pp. 1.082-1.085
[27.]
F. Des Vignes, J. Piesman, R. Hefferman, T.L. Schhulze, K.C. III Stafford, D. Fish.
Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophilia by Ixodes scapularis nymphs.
J Infect Dis, 183 (2001), pp. 773-778
[28.]
F.R. Matuschka, A. Spielman.
The vector of the Lyme disease spirochete.
N Engl J Med, 327 (1992), pp. 542
[29.]
S. Warshafsky, J. Nowakowski, R.B. Nadelman, R.S. Kamer, S. Peterson, G.P. Wormser.
Efficacy of antibiotic prophylaxis for prevention of Lyme borreliosis.
J Gen Intern Med, 11 (1996), pp. 329-333
[30.]
Antibiotic prophylaxis of Lyme disease following recognized bite: Bacterial Zoonoses Branch, Division of Vector-Borne Diseases National Center for Infectious Diseases, Centers for Diseases Control.
Con Med, 55 (1991), pp. 691-693
[31.]
G.P. Wormser, R.B. Nadelman, R.J. Dattwyler, D.T. Dennis, E.D. Shapiro, A.C. Steere, et al.
Practice guidelines for the treatment of Lyme disease.
Clin Infect Dis, 31 (2000), pp. S1-S14
[32.]
D. Magid, B. Schwartz, J. Craft, J.S. Schwartz.
Prevention of Lyme disease after tick bites: a cost-effectiveness analysis.
N Engl J Med, 327 (1992), pp. 534-541
[33.]
A. Estrada-Peña, J.A. Oteo, R. Estrada–Peña, C. Gortazar, J.J. Osácar, J.A. Moreno, J. Castellá.
Borrelia burgdorferi in ticks (Acari: Ixodidae) from two different foci in Spain.
Exp Acarol, 19 (1995), pp. 173-180
[34.]
C.M. Shih, R.J. Pollack, S.R. III Telford, A. Spielman.
Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice.
J Infect Dis, 166 (1992), pp. 827-831
[35.]
R.B. Nadelman, J. Nowakowski, D. Fish, R.C. Falco, K. Freeman, D. McKenna, et al.
Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.
N Engl J Med, 345 (2001), pp. 79-84
[36.]
E.D. Shapiro.
Doxycycline for tick bites – not for everyone.
N Engl J Med, 342 (2001), pp. 133-134
[37.]
A.C. Steeere.
Lyme disease.
N Engl J Med, 345 (2001), pp. 115-125
[38.]
R.T. Schoen, F. Meurice, C.M. Brunet, S. Cretella, D.S. Krause, J.E. Craft, et al.
Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease.
J Infect Dis, 172 (1995), pp. 1.324-1.329
[39.]
S.R. Telford, F.S. Kantor, Y. Lobet, S.W. Barthold, A. Spielman, R.A. Flavell, et al.
Efficacy of human Lyme disease vaccine formulations in a mouse model.
J Infect Dis, 171 (1995), pp. 1.368-1.370
[40.]
D. Keller, F.T. Koster, D.H. Marks, P. Hosbach, L.F. Erdile, J.P. Mays.
Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.
JAMA, 271 (1994), pp. 1.764-1.768
[41.]
Recommendations for the Use of Lyme Disease Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR, 48 (1999), pp. 1-17
[42.]
R.T. Schoen, V.K. Sikand, M.C. Caldwell, C. Van Hoecke, M. Gillet, C. Buscarino, et al.
Safety and immunogenicitiy profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.
Clin Ther, 22 (2000), pp. 315-325
[43.]
A.C. Steere, V.K. Sikand, F. Meurice, D.L. Parenti, E. Fikrig, R.T. Schoen, et al.
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant.
N Engl J Med, 339 (1998), pp. 209-215
[44.]
L.H. Sigal, J.M. Zahradnik, P. Lavin, S.J. Patella, G. Bryant, R. Haselby, et al.
A vaccine consisting of recombinant Borrelia burgdorferi outer–surface protein A to prevent Lyme disease.
N Engl J Med, 339 (1998), pp. 216-222
[45.]
M.I. Meltzer, D.T. Dennis, K.A. Orloski.
The cost effectiveness of vaccinating against Lyme disease.
Emerging Infect Dis, 5 (1999), pp. 321-328
[46.]
F.X. Heinz, C.W. Mandl.
The molecular biology of tick–borne encephalitis virus. Review article.
APMIS, 101 (1993), pp. 735-745
[47.]
C. Kunz.
Tick–borne encephalitis in Europe.
Acta Leidensia, 60 (1992), pp. 1-14
[48.]
P.N. Barrett, F. Dorner.
Tick–borne encephalitis vaccine.
eds. Vaccines. Second Edition, pp. 715-727
[49.]
K. Waldvogel, W. Bossart, T. Huisman, E. Boltshauser, D. Nadal.
Severe tickborne encephalitis following passive immunization.
Eur J Pediatr, 155 (1996), pp. 775-779
[50.]
Kunz C. The impact of a mass vaccination campaing on tick-borne encephalitis in Austria. En: 2nd International Symposium on Tick-borne encephalitis. Baden/Viena 6th- 7th June, 1991
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos